Ongoing and unsaid on oxaliplatin: the hope.
Oxaliplatin, the first available diaminocyclohexane platinum, has clinical activity in colorectal and ovarian cancers. Its mechanism of action is thought to be similar to that of cisplatin, its main mechanism being the intrastrand DNA adduct between two adjacent guanins or two adjacent guanine and a...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
1998
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149881/ |